Boron Neutron Capture Therapy (BNCT) Market: Size, Share, Growth, Analysis, Key Players, Revenue, Growth | Valuates Reports

Boron Neutron Capture Therapy (BNCT) Market Size
According to new survey, global Boron Neutron Capture Therapy (BNCT) market is projected to reach US$ 2090.2 million in 2029, increasing from US$ 96.6 million in 2022, with the CAGR of 51.3% during the period of 2023 to 2029.

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-11S15473/Global_Boron_Neutron_Capture_Therapy_BNCT_Market_Insights_Forecast_to_2029

Boron Neutron Capture Therapy (BNCT) Market
Boron Neutron Capture Therapy (BNCT) is a radiation science which is emerging as a hopeful tool in treating cancer, by selectively concentrating boron compounds in tumour cells and then subjecting the tumour cells to epithermal neutron beam radiation.
Benefits of BNCT:
Biophysical Precision
Effective in treating recurrent, multiple, and untreated cancers
Targets cancer at cellular level
Selectively destroys cancer cells
Eliminates the need for respiratory gating and internal markers
Efficient Treatment
One to two treatment sessions
Treats primary and undetected local microscopic cancer cells in parallel
Potential for more patient throughput than other radiation therapies
Better Patient Experience
Does not require high-level patient positioning, improving patient comfort and reducing staff workload
Potential to greatly reduce side effects and improve patient quality of life
The major global manufacturers of Boron Neutron Capture Therapy (BNCT) include Neutron Therapeutics, Sumitomo Heavy Industries, International Particle Therapy Inc (IPT), RaySearch, Neuboron Medtech, TAE Life Sciences, Stella Pharma, etc. The world's top five vendors accounted for approximately 58% of the revenue.
Asia-Pacific is the largest market, has a share about 61%, followed by North America, and Europe, with share24% and 13%, separately.
In terms of product type, Equipment is the largest segment, occupied for a share of 60%, and in terms of application, Head and Neck Cancer has a share about 55 percent.

Get regional report
https://reports.valuates.com/request/regional/QYRE-Auto-11S15473/Global_Boron_Neutron_Capture_Therapy_BNCT_Market_Insights_Forecast_to_2029

Segment by Type
• Equipment
• Solution
• Drug

Segment by Application
• Head and Neck Cancer
• Brain Tumor
• Others

By Company

Neutron Therapeutics, Sumitomo Heavy Industries, International Particle Therapy Inc (IPT), RaySearch, Neuboron Medtech, TAE Life Sciences, Stella Pharma

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-11S15473/global-boron-neutron-capture-therapy-bnct

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.